Vimarsana
Biggest News Aggregation in the World

Page 2 - Gary Roubin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gary Roubin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gary Roubin Today - Breaking & Trending Today

5 Penny Stocks To Buy With Up To 219% Upside According To Analysts | FinancialContent Business Page - Vimarsana News

5 Penny Stocks To Buy With Up To 219% Upside According To Analysts | FinancialContent Business Page

Are Analysts Right About These Penny Stocks To Buy? Who’s ready for another busy week with penny stocks? I know after a short week last week – and a volatile one at that – many are anticipating what to expect this week. Surely we’ll see continued attention on the pandemic and vaccine data. We’ve also got the outcome of the stimulus decision. Something else that’s becoming even more evident is the growing bullishness coming from retail traders. Brian Culpepper, a money manager at James Investment Research, told Bloomberg, “It’s been truly amazing. Every...

CGuard Carotid Embolic Protection Device Trial Will be Led by Chris Metzger - Vimarsana News

CGuard Carotid Embolic Protection Device Trial Will be Led by Chris Metzger

CGuard Carotid Embolic Protection Device Trial Will be Led by Chris Metzger InspireMD's MicroNet embolic protection mesh on stents is designed to prevent emboli during carotid stenting. February 9, 2021 — InspireMD Inc., developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced the appointment of Chris Metzger, M.D., system chair of clinical research at Ballad Health System in Eastern Tennessee as the principal investigator for its planned U.S. FDA registration trial for CGuard EPS. This upcoming trial will investigate ...